*Kenya, Ghana attract insurers, markets still modest. NAIROBI, Oct 31- Families gather at Nairobi's Garden Square restaurant each evening seeking donations from friends and relatives to meet spiralling medical, school and funeral costs. Changing attitudes and rising disposable incomes in many parts of Africa, from Kenya in the east to Ghana in the west, are...
Betadine-maker Mundipharma's new alliance with Manchester City all part of the pharma firm's EM strategy, the company told CNBC.
Mylan, Herbalife and T-Mobile are making headlines this Monday morning.
The pharmaceutical company will offer patients a two-pack carton at half price of the branded version.
Prescription drug prices are a mystery, but a new start up is disrupting prices for generic drugs across the country.
$21 billion is how much investors wiped off the firm after its trial to broaden the use of one of its most promising drugs failed.
Biotech startup NantHealth launched into the market Thursday after its initial public offering, with the stock surging nearly 33 percent.
A London start-up has invented a do-it-yourself DNA kit consumers can use to test the "athlete gene" — and other genetic identity markers.
A huge Hewlett Packard Enterprise project hopes to use massive data sets to better craft medical treatments and medicines for patients.
Scientists are one step closer in harnessing the power of genome sequencing to help improve the diagnosis and treatment of autism.
The Swiss pharmaceutical company struggles after a cheaper version of Gleevec launched in February.
With a grant from the Defense Department, a Florida medical center is creating a video game to train doctors for robotic surgery.
Michael Mussallem, Edwards Lifesciences CEO, talks about recent data on transcathether heart valves which show a minimally invasive procedure to replace the aortic heart valve is superior to open-heart surgery for patients with certain risks of complications.
It's hoped the FDA will approve an artificial pancreas in 2017. The device is expected to transform treatment of type 1 diabetes.
Bill Ackman should have listened!
The Zika virus is prompting bug spray manufacturer S.C. Johnson to ramp up production, reports CNBC's Mary Thompson.
New advances provide new hope for prosthetics, including an accurate sense of touch and robotic limbs developed at a fraction of the cost.
A $199 service from health company 23andMe gives individuals data from ancestry to risks of carrying a genetic condition.
Before testing your own genome, it helps to realize it can raise more questions than it answers.
Personalized medicine is more costly than traditional treatment, which worries insurers. But these drugs can improve outcomes for patients.